Ventavia Research Group was established by a vision to create a research company that would provide exceptional services to the clinical trial industry. This vision included three key factors: producing the highest quality data, ensuring subject safety, and only hiring professionals with unmeasurable integrity. Based in the Dallas/Fort Worth metroplex,
Ventavia Research Group serves as a comprehensive, multi-therapeutic research organization for inpatient and outpatient trials Phases I-IV. We pride ourselves in efficient turnaround time for all start-up activities such as regulatory submissions and contract/budgets negotiations. Our subject recruitment methods include an involved method of pre-screening to ensure good, quality subjects are participating. Our staff and investigators adhere to all ICH GCP standards and are committed to expedited data entry, in-house quality assurance, prioritizing subject safety, and maintaining a high level of professionalism through the entire process. In the development of new medications,
Ventavia Research Group understands the investigative site’s role is vital. We embrace all challenges and opportunities that arise within clinical research and are dedicated to ensuring each trial is conducted with the highest industry standards.
Winner of Small Business of the Year 2016
Placed 1st in the Emerging Business category
Flu Treatment Story with WFAA's Janet St. James in December 2014
Drug holds promise for treating the flu
Ventavia Research Group, LLC
Owners: Kristi Raney and Olivia Ray
Areas of expertise:
Employs a staff with over 75 years of combined experience in the industry.